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Abstract
Western blotting is a well-established, inexpensive and accurate way of measuring protein content. Because of technical
variation between wells, normalization is required for valid interpretation of results across multiple samples. Typically this
involves the use of one or more endogenous controls to adjust the measured levels of experimental molecules. Although
some endogenous controls are widely used, validation is required for each experimental system. This is critical when
studying transcriptional-modulators, such as toxicants like 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD).To address this issue,
we examined hepatic tissue from 192 mice representing 47 unique combinations of strain, sex, Ahr-genotype, TCDD dose
and treatment time. We examined 7 candidate reference proteins in each animal and assessed consistency of protein
abundance through: 1) TCDD-induced fold-difference in protein content from basal levels, 2) inter- and intra- animal
stability, and 3) the ability of each candidate to reduce instability of the other candidates. Univariate analyses identified
HPRT as the most stable protein. Multivariate analysis indicated that stability generally increased with the number of
proteins used, but gains from using .3 proteins were small. Lastly, by comparing these new data to our previous studies of
mRNA controls on the same animals, we were able to show that the ideal mRNA and protein control-genes are distinct, and
use of only 2–3 proteins provides strong stability, unlike in mRNA studies in the same cohort, where larger control-gene
batteries were needed.
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Introduction
2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) is a member of a
class of environmental contaminants, known as dioxins, and is
primarily produced through industrial processes including incin-
eration and manufacture of herbicides and pesticides [1,2] as well
as electronics recycling [3]. Exposure to TCDD evokes a wide
range of toxicities in laboratory animals, including wasting
syndrome and death [4]. In humans, short-term exposure to high
levels of TCDD often presents as liver damage and chloracne,
while low-dose long-term exposure has been linked to immune
deficiency [5], diabetes [6], and various cancer types [2,7].
TCDD is an exogenous ligand for the aryl hydrocarbon
receptor (AHR) [8]. Upon cell entry, TCDD binds cytoplasmic
AHR, leading to the formation of a ligand-receptor complex
which translocates into the nucleus, dimerizes with the AHR
nuclear translocator (ARNT) and binds to DNA to regulate
transcription of target genes [9]. Previous studies have shown
that TCDD exposure results in the dysregulation of hundreds of
genes in numerous models [10,11,12,13,14]. While specific
changes to the transcriptome resulting from TCDD-mediated
regulation have been identified across a wide range of
experimental models, downstream effects on the proteome which
may prove causative of toxicities, remain unclear. Complete
examination of various –omics data will be required to identify
the specific molecules responsible for the severe toxic effects
induced by TCDD.
Animal models have been, and will continue to be, crucial to
understanding the mechanisms described above [15]. In partic-
ular, the varying sensitivities to TCDD of different species and
strains of rodent greatly contribute to our understanding of
TCDD-mediated toxicities. For example, the Long-Evans rat
strain (Turku/AB; L-E) displays a very low tolerance for TCDD
(LD50 = 10 mg/kg) while the Han/Wistar rat (Kuopio; H/W) is
resistant to TCDD-induced lethality (LD50.9600 mg/kg) [16].
This difference in sensitivity is caused by a point mutation in the
H/W Ahr, resulting in expression of multiple isoforms of the
AHR [17], leading to differential regulation of a subset of genes
in H/W animals [18]. These differentially abundant transcripts,
and any ensuing changes to the proteome, may lead to strain-
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specific TCDD toxicities. Similarly, in mice, both the C57BL/6
and DBA/2 strains exhibit TCDD-mediated toxic effects,
however DBA/2 mice are much more resistant (approximately
10 to 20 times) than the C57BL/6 strain [19]. This resistance is
caused by a point mutation within the ligand binding domain of
the Ahr in the DBA/2 mice [20]. TCDD-toxicity also varies
between male and female animals within a species. Female rats
are more sensitive to TCDD-lethality than male rats, while in
mice this relationship is reversed [21].
Analysis of protein content is the general end-point for many
biological experiments. While mass spectrophotometry is a
highly sensitive and specific technique, both the data generation
and analysis steps are highly complex [22]. As such, western
blot has become the standard method of use, as it allows for the
sensitive and specific detection of target proteins with accurate
relative quantitation of protein content in a relatively simple
and inexpensive manner [23]. However, as in transcriptomic
studies, accurate assessment of protein abundance by western
blot requires thorough normalization of the data prior to the
interpretation of results. This normalization typically involves
the use of total protein or one or more endogenous loading
controls in order to account for technical variability and to
determine relative target abundance, thereby allowing multiple
samples to be compared. While measurement of total protein is
a relatively simple approach, it leads to complications down-
stream [24]. Specifically, coomassie stained gels cannot be
transferred to membrane for subsequent analysis and thereby
requires the assumption that simultaneously run gels are loaded
with identical amounts of protein [25]. The use of endogenous
controls bypasses the need for additional steps, thereby reducing
the number of gels and amount of sample used. Ideal
endogenous control proteins maintain consistent levels of
abundance regardless of environmental conditions, and thus
often perform functions essential for cell survival [26]. Glycer-
aldehyde-3-phosphate dehydrogenase (GAPDH) and beta-actin
(ACTB) have frequently been used as reference genes for both
mRNA expression measured by qPCR [26,27] and western blot
analyses of protein content [28]. However, studies have shown
that the stability of these widely used reference genes is not
always consistent under different experimental conditions
[29,30]. Factors such as tissue-type [30], organism (between
and within species) [31], experimental manipulation [32] and
even reagents used [33] can affect the abundance of candidate
reference molecules. For these reasons, it is essential that
endogenous reference proteins be thoroughly evaluated prior to
experimental use.
Investigations into TCDD-induced proteomic changes are
necessary to further our understanding of dioxin toxicity. Before
these studies can proceed, candidate reference proteins must be
carefully validated for use in western blot within the model
systems used. Several reference genes have been previously
validated for use in transcriptomic studies in rat [34] and mouse
models [31] of TCDD toxicity. Currently, reference proteins for
use in proteomic studies within these animal models have yet to
undergo thorough validation. Since the transcriptomic responses
differ dramatically across animal models [14,35], it is unclear
whether these validated transcriptomic reference genes will
translate to proteomic studies in either species. While it is not
necessary to use the same controls for assessments of both gene
and protein abundance, it is generally accepted that stably
expressed genes may result in consistent abundance of protein
[36,37]. We therefore chose to examine those genes previously
identified as suitable references for transcriptomic studies of
TCDD-toxicity [31], in addition to ACTB, to determine their
validity for proteomic studies. Seven candidate proteins (i.e.
ACTB, EEF1A1, GAPDH, HPRT, PGK1, PPIA and SDHA)
were tested in hepatic tissue from multiple mouse models of
TCDD-toxicity. This allows us to experimentally verify the idea
that similar controls can be used at the RNA and protein levels,
which would reduce the workload inherent in establishing
controls.
Table 1. Experimental Design.
Study Strain Sex Genotype Treatment (TCDD mg/kg)
Time of
tissue harvest
(hours)
Number
of animals
1 C57BL/6 Male WT 0, 500 6 4, 5
C57BL/6 Female WT 0, 500 6 4, 5
2 C57BL/6 Male rWT 0, 5, 500 19 4, 4, 4
DBA/2J Male Ala375Val 0, 5, 500 19 4, 4, 4
3 C57BL/6 Male WT 0, 500 24 4, 5
C57BL/6 Female WT 0, 500 24 3, 5
4 C57BL/6 Male WT 0, 500 72 4, 5
C57BL/6 Female WT 0, 500 72 4, 5
5 C57BL/6 Male WT 0, 500 144 3, 4
C57BL/6 Female WT 0, 500 144 3, 5
6 C57BL/6 Male WT 0, 125, 250, 500, 1000 96 4, 4, 4, 4, 4
7 C57BL/6 Male DEL 0, 125, 250, 500, 1000 96 5, 4, 3, 3, 4
8 C57BL/6 Male INS 0, 125, 250, 500, 1000 96 5, 4, 4, 4, 5
9 C57BL/6 Male rWT 0, 125, 250, 500, 1000 96 5, 3, 1, 4, 3
10 C57BL/6 Female WT 0, 125, 250, 500, 1000 96 5, 5, 4, 4, 5
Animals analyzed (n = 192) varied in strain, sex, Ahr-allele, TCDD-treatment and time-point at which tissue was collected.
doi:10.1371/journal.pone.0110730.t001
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Methods
Ethics Statement
All study plans were approved by the Finnish National Animal
Experiment Board (Ela¨inkoelautakunta, ELLA; permit code:
ESLH-2008-07223/Ym-23).
Animal Handling
Animal models and handling have been described previously
[31]. Briefly, mouse colonies were maintained at the National
Public Health Institute (today National Institute for Health and
Welfare), Division of Environmental Health, Kuopio, Finland.
Male and female C57BL/6 wild-type mice [21], male transgenic
mice [38] and male DBA/2J mice [21] were studied. Wild-type
animals were 12–15 weeks old and transgenic mice ranged up to
23 weeks. Animals were housed singly to avoid aggressive social
behaviour, with environmental conditions maintained at 2161uC
with a relative humidity of 50 6 10% on a 12 hour light cycle
(12 hours of light followed by 12 hours of dark). Housing consisted
of suspended, wire-mesh stainless-steel cages or Makrolon cages
with aspen chip bedding (Tapvei Oy, Kaavi, Finland) and animals
were provided with Altromin 1314 pellet feed (Altromin
Spezialfutter GmbH & Co. KG, Lage, Germany) and water
available ad libitum. The microbiological status of the animal
facilities was regularly monitored in compliance with the
recommendations of the Federation of European Laboratory
Animal Science (FELASA), but individual mice were not tested in
this regard. All experimental animals were drug and test naı¨ve.
Initial body weights for each animal are provided in Table S6.
Animals were stratified according to age such that groups
contained a similar age-range, followed by randomization into
experimental groups. Mice were treated in a group-wise manner,
starting with the control in order to minimize the chance of human
error. In most cases, the administration for a group was
accomplished within an hour. Mice were treated with TCDD or
corn oil vehicle alone and assessed following both timecourse and
dose-response studies as described previously [31]. A total of 192
mice were used distributed across 47 separate experimental
conditions (Table 1, Figure S1). TCDD was dissolved in corn oil
and administered by oral gavage (10 mL/kg). Mice treated with
corn oil alone acted as controls in each experiment.
Briefly, animals in the timecourse study were treated with a
single dose of TCDD (500 mg/kg) or corn oil alone at time zero,
followed by euthanasia at different time points (animals with tissue
collected at the 19 hour time point received either 0, 5 or 500 mg/
kg TCDD). Animals in the dose-response study received a single
dose of 0, 125, 250, 500 or 1000 mg/kg TCDD followed by
euthanasia 96 hours post-treatment. Although some of these doses
were above the LD50 level of the exposed animals, the exposure
time was in all cases maximally about 50% of the shortest time-to-
death for these strains and genetic models as recorded in previous
studies [21,33], and no mortality was therefore expected.
However, all animals were carefully observed at least twice daily
throughout the experimental period and, should signs consistent
with severe suffering have been detected, those animals would
have been euthanized immediately, as per the approved animal
study plans.
Mouse livers were excised and snap-frozen in liquid nitrogen
following euthanasia by carbon dioxide exposure. Tissue was
shipped on dry ice to the analytical laboratory and stored at 2
80uC or colder. All animal handling and reporting comply with
ARRIVE guidelines [39].
Western analysis
Protein levels for candidate genes were determined by
quantitative western blot. Each experiment was assessed on a
single western blot to ensure identical analysis conditions between
treated and control animals. Total protein was isolated from
mouse liver using Tissue Extraction Reagent I (Life Technologies,
Burlington, ON) supplemented with cOmplete protease inhibitor
cocktail (Roche, Laval, QC). Protein extract, diluted 1/10 and 1/
20 with 1XPBS, was quantified by Bradford assay and diluted to a
final concentration of 10 mg/mL. A total of 65 mg protein [40,41]
was loaded into each well of a Novex 4–12% Bis-Tris midi-gel
system to ensure sufficient material would be available for the
detection of low abundance targets [42]. Prepared gels were then
electrophoresed for 40 minutes at 200V with MES running buffer
(Life Technologies). Protein was transferred to PVDF membrane
with the iBlot system using program P0 for 7 minutes (Life
Technologies). The Colloidal Blue Staining Kit (Life Technolo-
gies) was used to observe total protein before and after
electrophoresis and Ponceau staining was performed on the
transferred membrane to ensure sufficient protein transfer
(Figure S4). While there is some variation between samples,
protein transfer appears consistent. Primary antibodies were
purchased from Santa Cruz (Santa Cruz Biotechnology Inc.,
Table 2. Summary of analysis methods.
NormFinder
Student’s t-test Training Validation Normalization Method
ACTB 6/28 0.092 0.060 996.59
EEF1A1 11/28 0.112 0.050 278.40
GAPDH 5/31 0.072 0.077 316.07
HPRT 1/31 0.078 0.046 306.46
PGK1 6/29 0.144 0.081 259.58
PPIA 8/31 0.140 0.066 366.06
SDHA 10/26 0.071 0.056 286.62
Three analysis methods were used to evaluate the abundance consistency of each individual candidate protein; values in bold indicate the top ranked score for each
method. 1) The difference between treated and untreated animals for each experimental condition was assessed by Student’s t-tests; a p-value ,0.05 was deemed
significant. 2) The variation of each candidate was assessed using the NormFinder algorithm in two separate cohorts; a lower score indicates greater stability. 3) The
comparative normalization method was used to evaluate the ability of each candidate to remove variation from a dataset; the average standard deviation for each pair-
wise comparison is reported.
doi:10.1371/journal.pone.0110730.t002
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Dallas, TX) or Abcam (Abcam Inc., Toronto, ON) and were
diluted at the recommended concentrations in Li-Cor blocking
buffer supplemented with 0.1% Tween-20, with overnight
incubation at 4uC. Blots were washed three times with PBS
supplemented with 0.1% Tween-20 at room temperature for
5 minutes each. The Li-Cor IRDye-labelled secondary antibodies
(Mandel Scientific, Guelph, ON) were used at a dilution of
1:10,000 in Li-Cor blocking buffer supplemented as above with
0.01% SDS and incubated at room temperature for 1 hour
(ordering information and optimal dilutions for all antibodies are
provided in Table S1). After washing as described, blots were
scanned and analyzed with the Odyssey quantitative western blot
near-infrared system (Li-Cor Biosciences, Lincoln, NE, USA)
using default settings. Antibodies were initially tested individually
and then grouped based on banding patterns in order to reduce
the number of blots required [43]. Average band intensities were
normalized by subtraction of background levels. Background
normalized values are provided in Table S2 and scanned images
in Figure S2. Primary and secondary antibodies were initially
tested individually to identify optimal concentrations for the
reduction of nonspecific banding patterns. Antibodies were then
grouped where possible such that desired bands did not overlap.
Statistical Analyses and Visualization
Data were loaded in the R statistical environment (v3.0.3) for all
analyses. Protein content was aggregated across biological
replicates to obtain a mean abundance with standard for each
candidate protein. Aggregation into biological replicates resulted
in 47 separate experimental conditions. The ratio between treated
and control abundances provided the fold-difference (M) in
expression. Individual proteins and all possible combinations of
multiple proteins were assessed. Visualizations were produced
using the lattice (v0.20–29) and latticeExtra (v0.6–26) R packages.
Protein content was assessed across timecourse and dose-
response studies. Animals treated with TCDD were compared to
control animals of the same experimental group resulting in 26–31
comparisons (some comparisons were not done due to unsatisfac-
tory loading patterns and/or lack of sufficient sample). Differential
Figure 1. Timecourse and Dose-response by Treatment Group. The fold-differences in protein abundance between treated and control
animals were calculated and results compared across all conditions. (A) Timecourse and (B) dose-response studies were visualized. Points represent
the fold change in abundance (in log2 space) and error bars indicate the standard deviation for each experimentally unique group.
doi:10.1371/journal.pone.0110730.g001
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abundance resulting from exposure to TCDD was evaluated for
each candidate using an unpaired, two-tailed Student’s t-test with
Welch’s adjustment for heteroscedasticity. Results were visualized
as M 6 standard-deviation for all experimental conditions.
Protein stability was evaluated using the NormFinder algorithm,
which estimates the overall variation of a dataset by analysing its
variance both within an experimental group and across experi-
mental conditions [44]. Prior to analysis, animals were categorized
into one of two groups (TCDD-treated or control) to estimate
variance within experimental groups. Experiments were then split
into 2 cohorts, labelled training (including experiments 1, 4, 6, 8
and 9) and validation (consisting of experiments 2, 3, 5, 7 and 10),
such that each cohort contained similar types and number of
animals and each cohort was analysed independently of the other.
For each combination of candidates, the geometric mean of the
background-normalized protein levels was calculated for each
animal. For interpretation, a lower score indicates higher
consistency of input across experimental groups signifying a
potentially good loading control. Stability scores are available in
Table S3. Linear modelling was performed to identify the
contribution of each candidate protein [YOS = aACTB + aEEF1A1
+ aGAPDH + aHPRT + aPGK1 + aPPIA + aSDHA + e] where YOS
represents the overall stability of each combination of candidates
and each protein is a Boolean variable indicating presence/
absence in the combination while epsilon represents any error in
the observations not explained by the model.
The comparative normalization method was used to contrast
abundance levels between pairs of candidate molecules for each
sample (adapted for use with protein abundance data from the
comparative DCq method [45]). The ability of each candidate to
remove variability from other proteins was assessed and the mean
standard deviation across comparisons provided a measure of
stability.
mRNA analysis of candidate reference genes was reported
previously for these animals and Cq data were downloaded
(Supplementary Table 2, [31]); protein abundance and mean Cq
data are provided in Table S4 for each animal. The correlation
between protein levels and mean Cq values for each gene was
assessed using Spearman’s correlation using the AS89 method to
assess statistical significance. NormFinder-generated stability
scores were compared using the Spearman’s correlation metric
as the ordering of the scores is more meaningful than the
magnitude (data available in Table S5).
Results
Quantitation of protein abundance by western blot is an
essential technique widely used in the scientific community. In the
past, this was typically performed using chemiluminesence.
However, the Odyssey Infrared Imaging System is a well-
documented alternative that provides many benefits over earlier
methods, including an enhanced dynamic range of detection.
Additionally, this system has the capacity for multiplexed
reactions; specifically, antibodies are conjugated to IR fluoro-
phores that can be detected at different wavelengths. As such, this
system is ideal for detecting multiple targets [46].
Univariate Analysis
A good reference gene is one whose abundance is consistent
across a wide range of conditions. This is most easily detected
through analysis of the fold-difference (M) in expression from basal
levels across specific treatment conditions. Candidate abundance
was compared across conditions. Moderate correlations were
observed between HPRT and PGK1 (Pearson’s correlation,
R = 0.6) as well as EEF1A1 and SDHA (R = 0.49), while the
remaining candidates were weakly correlated (Figure S3).
To better understand this variation, each experimental group
was examined individually (Figure 1). Of the 31 different
experiment groups and 192 animals for which protein data were
obtained (and for which mRNA data were obtained previously),
HPRT was significantly altered by TCDD in only one group and
GAPDH (5/31 conditions significantly altered) was also consistent,
while the remainder of targets displayed less consistency, with
greater than 20% of conditions altered (Table 2). To verify our
samples and approach, the prototypical Ahr-regulated gene,
CYP1A1, was examined as above and was determined to be
significantly altered by TCDD at the protein level across all 31
conditions, as expected (Figure 1).
As this evaluation of differences in TCDD-altered abundance
only accounts for variation within a single treatment, individual
candidate stability across all experimental conditions was
assessed using the NormFinder algorithm [44]. Briefly, Norm-
Finder estimates the overall numerical stability of a molecule
based on variability within a single treatment condition,
variation within and between multiple conditions and systemic
variation between experimental runs. Lower stability scores
indicate less variation while higher scores indicate greater
instability across experiments. As with our previous analysis of
reference genes for transcriptomic analysis [31], experiments
were organized into training and validation sets, thereby
evaluating protein stability in two independent cohorts (Fig-
ure 2, Table 2). Although the cohorts differed in the magnitudes
of stability scores, HPRT and SDHA were consistently amongst
the most stable of the candidates, while PGK1 and PPIA were
consistently the most unstable of the proteins evaluated.
To ensure that our results are not confounded by a shift in
abundance caused by technical variation and independent of
Figure 2. Univariate Analysis of Candidate Stability. Animals
were separated into training and validation cohorts based on
experiment, ensuring similar treatment conditions and animal numbers
appeared in both sets. Within each cohort, animals were categorized as
either TCDD-treated or control. Candidate proteins were analyzed using
the NormFinder algorithm to determine stability across all treatment
groups. A lower value indicates less variance across all experimental
conditions.
doi:10.1371/journal.pone.0110730.g002
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TCDD-treatment, we applied an alternate univariate analysis
technique. Under typical experimental settings, it would be the
purpose of the reference gene to normalize abundance levels for
this shift. To this end, abundances of 6 proteins from each
animal were normalized using the 7th, and the variance across
technical replicates evaluated. This process was repeated using
each protein as the normalization candidate. Using this
approach, a lower score indicated greater stability across a
dataset resulting from normalization with the given candidate
protein (Table 2). By this method, PGK1 and EEF1A1 were
determined to be the most stable of candidate proteins while
ACTB was responsible for increased variation, likely due to the
difference in magnitude of the intensity values between targets
(intensity values for ACTB are significantly higher than for
other candidates). Surprisingly, while PGK1 was identified as
one of the more variable candidates both by analysis of fold-
differences and the NormFinder algorithm, it was among the
most stable candidates by this normalization method.
Multivariate Analysis
It has previously been shown that the use of multiple reference
genes can improve normalization [31,47]. Although this generally
applies to more high-throughput technologies capable of analyzing
a large number of genes simultaneously, we evaluated the
usefulness of utilizing multiple controls for western blot studies.
The normalization capabilities of each possible combination of our
candidate proteins were tested using the NormFinder algorithm, as
described above. In general, including more control genes
improved stability; however, specific pairs of candidates, and even
some individual candidates, showed greater stability than some
larger combinations (Figure 3A). Within each subset of samples,
candidate combinations generally performed similarly; however,
the training cohort demonstrated slightly more variance among
samples (Pearson’s correlation = 0.64) (Figure 3B). Despite this,
the combination of all 7 candidates displayed the greatest stability
in both cohorts (Figure 3C).
As a greater instability score appeared to primarily result from
the inclusion of select candidates, linear modeling was performed
to examine the contribution of each candidate to overall stability.
Figure 3. Multivariate Analysis of Candidate Stability. Animals were categorized as either TCDD-treated or control and separated into training
and validation cohorts. All possible combinations of candidates were analyzed using the NormFinder algorithm. A lower value indicates less variance
across all experimental conditions. (A) Combinations of candidates were organized according to the number of proteins included, in order to
determine the optimal number of proteins used. (B) Stability results for each combination of candidates were compared between the training and
validation sets to assess concordance. (C) Results for each combination of gene(s) were plotted for both the training (+) and validation (N) cohorts.
Combinations are organized according to performance in the training set.
doi:10.1371/journal.pone.0110730.g003
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ACTB and PGK1 decreased stability while GAPDH, HPRT and
PPIA significantly increased stability (Figure 4).
Comparison with mRNA
As a similar analysis on the mRNA abundance of these
candidates had been previously conducted in the liver of these
animals, we thus compared the mRNA and protein abundances
for each candidate. Spearman’s correlation was used to determine
whether protein abundance was concordant with mRNA levels. In
general, there was little to no correlation between these molecules,
possibly indicating differential regulation of translational mecha-
nisms or variation in stability of the protein (Table 3, Figure 5A).
To verify this, stability scores for each dataset generated by
NormFinder were combined, and the overlapping gene combina-
tions compared (Figure 5B). Interestingly, while the abundance
patterns of these candidates varied, combinations of candidates
generally demonstrated similar stability (Spearman’s correlation
= 0.5, p = 3.6561025). Among the candidates (independently or in
combination) that overlapped between studies, HPRT was among
the most stable individual genes while the partnership of HPRT
and GAPDH was consistently the most stable pair of candidates.
Beyond this, the order of combination stability varied, sometimes
dramatically, between data types. For example, the combination of
EEF1A1, GAPDH and PPIA proved highly stable within the
mRNA data, but was among the most unstable within the protein
dataset. Alternatively, the pair-wise combination of EEF1A1 and
PGK1 was among the most stable within the protein data and
among the least stable in the mRNA data (Table S5).
Discussion
Thorough validation of reference genes is essential prior to any
quantitative experimentation. Whether for evaluation of mRNA
or protein abundance, all experimental methods are prone to some
variation; the general rule is that each step in a process will
introduce some error. This error may not be noticeable
throughout the process, and only becomes apparent in down-
stream analyses, such as molecule quantitation. To ensure
accurate interpretation, it is imperative to account for this
technical variation. Estimation of target values relative to a
reference molecule, whether internal or exogenous spike-in control
is a proven method across technologies [48,49]. In the case of an
endogenous molecule reference, careful validation must first occur
as it has been shown that even classically-used controls can differ
in abundance across different sample types or even by sample
handling methods. For example, Gapdh was found to be less stable
over time in FFPE breast tumour samples by qRT-PCR [50]
whereas it was deemed a suitable reference gene for use in lung
tumour FFPE samples [51]. In a proteomic analysis, multiple
species of GAPDH were identified within human platelet samples;
of these, the most abundant of species was highly variable across
Figure 4. Linear Modelling of Multivariate Results. Linear
modelling was performed to identify the contribution of each candidate
to stability as determined by NormFinder across the complete dataset
bars are coloured according to FDR-corrected p-value; error bars
indicate standard error within the model; negative values are
representative of decreased variation (increased stability).
doi:10.1371/journal.pone.0110730.g004
Figure 5. Comparison of candidate mRNA and protein abundances.mRNA and protein abundances as determined by qPCR and quantitative
western blot were compared for each candidate. (A) Spearman’s correlation was used to compare mean Cq values across technical replicates for qPCR
and protein intensity for candidate genes and visualized in a heatmap organized using divisive clustering: blue indicates perfect correlation, green
indicates inverse correlation and black indicates little or no correlation. Note that an increasing mRNA abundance results in a lower Cq; hence an
inverse correlation indicates similarity between molecule abundances. (B) Spearman’s correlation was used to assess similarity in candidate
combination stability calculated by NormFinder for each data type.
doi:10.1371/journal.pone.0110730.g005
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both age and sex [52]. This indicates that particular effort must be
made when validating loading controls for western blot, as
different antibodies may target different species.
Exposure to TCDD has been shown to have a dramatically
different effect on transcriptomic regulation across various animal
models. This has been shown to result from ligand activation of the
AHR by TCDD-binding [8] while the degree of toxicity is directly
related to the Ahr-genotype within rodents. While studies into the
specific transcriptomic changes responsible for overall toxicity are
still ongoing, progress has been made in the identification of
candidate lists within various animal models, including strains of
rats [53,54] and mice [55]. However, as toxicity likely results from
subsequent changes in the proteome, further studies are required
to verify which of these candidate genes are concomitantly altered
at the protein level. While validation of reference genes for RNA
quantitation in various mouse models has been completed [31],
there is no reason to expect similar results to be obtained at the
level of the proteome.
Here, we have evaluated the protein abundance of 7 reference
genes for use in toxico-proteomic analyses of TCDD-induced
toxicity within a wide range of mouse models. In particular, we
have assessed the effect of TCDD exposure on protein abundance
within mouse models of various strains, Ahr-genotype and sex
across both a timecourse and dose-response approach. Protein
abundance was assessed by quantitative western blot analysis and
each candidate’s suitability as a reference control was evaluated
using 3 analysis methods: 1) the fold-difference in protein content
from basal levels, 2) the NormFinder algorithm [44], which is an
assessment of target stability and 3) the ability of each candidate to
reduce instability of the others [45].
As TCDD is known to have a significant impact on
transcriptional regulation, and has been shown to affect the
proteome [56], the protein abundance of our candidates was first
assessed using biologically similar animals that were treated with
either TCDD (at various doses) or corn oil alone. HPRT was
identified as the protein least affected by TCDD while EEF1A1
and SDHA showed significant variability across multiple exper-
imental conditions (Figure 1, Table 2). The suitability of this
method is proven through the evaluation of CYP1A1; a protein
involved in the detoxification of xenobiotics known to be
significantly induced by TCDD. As well, since data for both
treated and control animals were generated on a single western
blot (experiencing identical experimental settings), this metric was
arguably the most appropriate for our goals. Next, as the purpose
of a reference gene is to efficiently remove technical variation from
the quantified results, we sought to characterize the residual
variability among the remaining proteins after normalization with
each candidate. An assumption of this method is that all candidate
proteins demonstrate consistent expression over experimental
conditions and that increased variation indicates decreased
stability of the candidate in question [47]. Here we identified
EEF1A1 and PGK1 as the most consistently expressed candidate
genes while PPIA was again determined to be the least stable
candidate (Table 2). The high instability of ACTB should be
interpreted with caution as it does not follow the above
assumption. One limitation of this approach is its disregard for
technical considerations; since each western blot contained a
separate experiment, and were performed one at a time, some
technical variation would be inherent across the entire study.
Finally, unlike the above comparative method, the NormFinder
algorithm considers variation both within and between experi-
ments in its assessment of candidate stability [44]. While the
specific order of stability varied, NormFinder analysis identified
HPRT, ACTB and SDHA as the most stable candidates in all
cohorts examined (training, validation and overall). Similarly,
PGK1 and PPIA were always deemed the most unstable
candidates. The consistency in stability scores for each candidate
protein verifies that NormFinder is a robust and reproducible
method for identifying good reference proteins.
A major finding of our previous study of reference gene stability
in qPCR studies was that greater stability was obtained through
increasing the number of reference genes used. This finding was
consistent with other reference gene validation studies [47,57]. In
order to determine whether this finding was consistent with
proteomic analysis, NormFinder analysis was applied as above. In
general, the trend of increasing stability was consistent with the
inclusion of an increasing number of candidates (Figure 3).
However, due to the low-throughput nature of any western blot
analysis, increasing the number of reference proteins is largely
impractical. Therefore, careful selection of 2 or 3 candidates with
good stability would prove ideal. In some cases, even a single
reference gene could provide a more stable normalization factor
than a larger, less consistently expressed group of candidates. To
this effect, linear modelling of the multivariate analysis indicated
that 2 of the 3 most stable candidates identified in the univariate
analysis (HPRT and SDHA) each contributed significantly to
increased stability when included in combinations of any number
of candidates (Figure 4) while PGK1 contributed less.
The availability of both mRNA and protein abundances
collected from the same 192 animals presented an interesting
opportunity, as an in-depth comparison of these molecules for
these candidate genes across such a wide range of conditions has
Table 3. Comparison between mRNA and protein abundances.
Spearman’s correlation
r p-value
EEF1A1 20.02 0.79
GAPDH 0.13 0.08
HPRT 0.17 0.02
PGK1 0.11 0.14
PPIA 20.15 0.04
SDHA 20.06 0.46
Spearman’s correlation was used to evaluate concordance between mRNA and protein abundances as determined by qPCR (mean Cq of technical replicates) and
western blot (log2 of the protein intensity). Note that an increasing mRNA abundance results in a lower Cq; hence an inverse correlation indicates similarity between
molecule abundance.
doi:10.1371/journal.pone.0110730.t003
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yet to be performed. We sought to determine whether targets
selected as optimal reference genes at the level of mRNA would be
suitable for normalization of protein abundance data. A compar-
ison of abundance levels suggested little or no correlation between
molecules (Table 3). The largest correlation coefficient, though
showing an inverse relationship in abundance, was observed for
HPRT. While analysis of the fold-changes identified HPRT as
most stable univariate candidate at the protein level, it was much
less stable at the level of mRNA abundance. However, it
consistently ranked among the most stable genes across all analysis
methods in each study. Alternatively, the least stable gene
identified in the RNA study, Sdha, ranked among the most stable
in the current protein analysis and did not show correlation
between molecules. As such, the optimal reference gene for studies
of mRNA abundance may not be optimal for studies of protein
abundance and should be validated prior to use. Conversely,
multivariate analysis by NormFinder generated stability scores that
were moderately correlated between data types and, in general,
these scores improved with the addition of an increased number of
genes. Even so, the practicality of using a larger number of genes is
limited by the technology used and must be taken into
consideration. As such, while using a larger number of genes is
encouraged for studies easily multiplexed (such as qPCR), careful
selection of fewer genes is required for low-throughput methods
such as western blot.
For any type of quantitative analysis, data must be thoroughly
normalized in order to account for the technical variation inherent
in any experiment and to ensure reliable and reproducible results.
The use of multiple controls is ideal for generation of a
normalization factor; however, a carefully selected group of fewer
candidates can prove sufficient when larger numbers are
impractical. Here we have identified and suggested specific
combinations of loading controls, such as HPRT alone or
combined with ACTB or GAPDH, for use in western blot
analysis of various mouse models of TCDD toxicity.
Supporting Information
Figure S1 Experimental Design. Mice were treated with
either 0, 5, 125, 250, 500 or 1000 mg/kg TCDD dissolved in corn
oil vehicle and euthanized at 6, 19, 24, 72, 96 or 144 hours post-
exposure. Timecourse experiments followed male (blue) and
female (pink) wild-type C57BL/6 mice treated with 500 mg/kg
TCDD. Male DBA/2J and ratonized-WT mice were collected at
19 hours post-exposure following treatment with either 5 or
500 mg/kg TCDD. Dose-response experiments followed male
(blue) wild-type or ratonized mice and female (pink) wild-type mice
treated with a single dose of TCDD and euthanized 96 hours
following exposure.
(PPT)
Figure S2 Western blots. Western blots were scanned and
analyzed with the Odyssey quantitative western blot near-infrared
system using default settings. Each blot was scanned twice as two
groups of antibodies were used. Wells with unusual loading
patterns (noted by the *) were not used in the downstream analysis.
(PPT)
Figure S3 Correlation of Candidate Proteins. The fold-
difference in abundance between treated and control groups were
calculated for each experimental condition and Pearson’s
correlations applied. Correlation results were visualized using a
heatmap and organized by divisive clustering. Blue indicates
perfect correlation; green represents inverse correlations while
black indicates little or no correlation. Pearson’s correlations are
shown in white for each pair-wise comparison.
(TIF)
Figure S4 Ponceau Stain. Total protein abundance was
assessed in a representative gel using Colloidal Blue Stain pre-
(A) and post-transfer (B). Total protein was quantified and
background-normalized intensity values were visualized for both
gels (C). Transferred protein was also visualized on the membrane
(D) using Ponceau stain. Lanes labelled in black indicate untreated
samples, while blue labels are TCDD-treated (500 mg/kg) samples.
The first four lanes show increasing amounts of loaded protein.
(PPTX)
Table S1 Antibody Information.
(XLS)
Table S2 Protein Abundances.
(XLSX)
Table S3 NormFinder Stability Scores.
(XLS)
Table S4 Comparison of mRNA and Protein Abundanc-
es.
(XLS)
Table S5 Comparison of mRNA and Protein Stability
Scores.
(XLS)
Table S6 Animal Information.
(XLS)
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